Moreover, assessment of the correlation between SLC30A family genes expression levels and the tumor stages of GC patients indicated that the expression levels of most SLC30A family genes, including SLC30A1, 5–7, and 9, were significantly and positively associated with tumor stage in GC patients. The gene discussed is SLC30A1; the disease is gastric cancer.